Literature DB >> 201606

Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants.

M D Alper, B N Ames.   

Abstract

Mutants in the cyclic AMP (cAMP) control system in Salmonella typhimurium (cya = adenyl cyclase, crp = cAMP receptor protein) were partially resistant to growth inhibition by 22 antibiotics (including fosfomycin, nalidixic acid, and streptomycin) and 29 inhibitory analogs of normal bacterial fuel/carbon sources. This resistance was used as the basis for an efficient positive selection of cya and crp mutants. We propose that these antibiotics and analogs enter the bacteria through transport systems normally used for transporting fuel/carbon sources and that this is accomplished because of a structural similarity between the antibiotic and the natural substrate of the particular transport system involved. We propose that these transport systems are all under positive control by cAMP and that cAMP acts as a signal molecule (alarmone) for fuel/carbon deprivation. Evidence is provided for a hierarchy within operons controlled by cAMP. The methodology is shown to be useful for analyzing both antibiotic transport systems and the cAMP super-control system.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 201606      PMCID: PMC221988          DOI: 10.1128/jb.133.1.149-157.1978

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  49 in total

1.  Properties of adenyl cyclase and cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli.

Authors:  S Kumar
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

2.  Regulation of intracellular adenosine cyclic 3':5'-monophosphate levels in Escherichia coli and Salmonella typhimurium. Evidence for energy-dependent excretion of the cyclic nucleotide.

Authors:  M H Saier; B U Feucht; M T McCaman
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

3.  Cyclic 3', 5'-adenosine monophosphate phosphodiesterase mutants of Salmonella typhimurium.

Authors:  M D Alper; B N Ames
Journal:  J Bacteriol       Date:  1975-06       Impact factor: 3.490

4.  Deletion of the Escherichia coli crp gene.

Authors:  D Sabourin; J Beckwith
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

5.  Adenosine 3':5'-cyclic monophosphate as mediator of catabolite repression in Escherichia coli.

Authors:  W Epstein; L B Rothman-Denes; J Hesse
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

Review 6.  Cyclic adenosine 5'-monophosphate in Escherichia coli.

Authors:  I Pastan; S Adhya
Journal:  Bacteriol Rev       Date:  1976-09

7.  On the transport of tripeptide antibiotics in bacteria.

Authors:  H Diddens; H Zähner; E Kraas; W Göhring; G Jung
Journal:  Eur J Biochem       Date:  1976-06-15

8.  Effects of crp mutations on adenosine 3',5'-monophosphate metabolism in Salmonella typhimurium.

Authors:  A W Rephaeli; M H Saier
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

9.  Regulation of carbohydrate permeases and adenylate cyclase in Escherichia coli. Studies with mutant strains in which enzyme I of the phosphoenolpyruvate:sugar phosphotransferase system is thermolabile.

Authors:  L Castro; B U Feucht; M L Morse; M H Saier
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

10.  Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium.

Authors:  J C Cordaro; T Melton; J P Stratis; M Atagün; C Gladding; P E Hartman; S Roseman
Journal:  J Bacteriol       Date:  1976-12       Impact factor: 3.490

View more
  103 in total

1.  A long T. A tract in the upp initially transcribed region is required for regulation of upp expression by UTP-dependent reiterative transcription in Escherichia coli.

Authors:  Y Cheng; S M Dylla; C L Turnbough
Journal:  J Bacteriol       Date:  2001-01       Impact factor: 3.490

2.  Mutational analysis of the histidine operon promoter of Salmonella typhimurium.

Authors:  R F Shand; P H Blum; D L Holzschu; M S Urdea; S W Artz
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

3.  Factors affecting start site selection at the Escherichia coli fis promoter.

Authors:  Kimberly A Walker; Robert Osuna
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

4.  Lateral flagellar gene system of Vibrio parahaemolyticus.

Authors:  Bonnie J Stewart; Linda L McCarter
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

5.  Translational control of pyrC expression mediated by nucleotide-sensitive selection of transcriptional start sites in Escherichia coli.

Authors:  H R Wilson; C D Archer; J K Liu; C L Turnbough
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

6.  Multiple paths for nonphysiological transport of K+ in Escherichia coli.

Authors:  Ed T Buurman; Debbie McLaggan; Josef Naprstek; Wolfgang Epstein
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

7.  Multiple control mechanisms for pyrimidine-mediated regulation of pyrBI operon expression in Escherichia coli K-12.

Authors:  C G Liu; C L Turnbough
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

8.  Toxicity of the pyrimidine biosynthetic pathway intermediate carbamyl aspartate in Salmonella typhimurium.

Authors:  C L Turnbough; B R Bochner
Journal:  J Bacteriol       Date:  1985-08       Impact factor: 3.490

9.  Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes.

Authors:  J O Hassan; R Curtiss
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Regulation of the put operon in Salmonella typhimurium: characterization of promoter and operator mutations.

Authors:  D R Hahn; S R Maloy
Journal:  Genetics       Date:  1986-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.